NCT02401139View on ClinicalTrials.gov

Ketamine Trial for the Treatment of Depression

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

September 30, 2015

Conditions
Unipolar Depression
Interventions
DRUG

Ketamine

DRUG

Placebo

Trial Locations (2)

2031

Black Dog Institute, University of New South Wales, Sydney

2050

Brain & Mind Research Institute (BMRI), University of Sydney, Camperdown

All Listed Sponsors
collaborator

University of Sydney

OTHER

lead

The University of New South Wales

OTHER

NCT02401139 - Ketamine Trial for the Treatment of Depression | Biotech Hunter | Biotech Hunter